Clinical Trial

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

Name: Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre — clinical trial record (NCT07687186)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).

Trial Details

NCT Number	NCT07687186
Lead Sponsor	Tasly Pharmaceutical Group Co., Ltd
Conditions	Heart Failure
Enrollment	636 participants
Start Date	2026-06-22
Primary Completion	2028-06-22 (estimated)
Study Completion	2028-06-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-07